If you made any changes in Pure these will be visible here soon.

Personal profile

Experience

  • Professor, Graduate Institute of Clinical Medicine, Taipei, Medical University (2010.10~now)
  • Deputy Director, Department of Human Research, Taipei, Medical University (2015.10~now)
  • Chief, Department of Medical Affairs, Shuang Ho Hospital, Taipei Medical University (2015.02~now)
  • Director, Joint Clinical Research Center, Taipei, Medical University (2014.02~2015.09)
  • Chief and Professor, Division of Hematology/Oncology, Shuang-Ho Hospital, Taipei Medical University, (2010.10~now)
  • Chief and Professor, Division of Internal Medicine, Shuang-Ho Hospital, Taipei Medical University, Taipei, Taiwan, (2010.10~2015.01)
  • Chief and Professor, Division of Hematology/Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, (1997.5~2010.9)
  • Attending Physician, Division of Hematology/Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, (1992.09~1997.06)
  • Research Fellow, Department of Immunology and Biochemistry Research, Roswell Park Memorial Institute, (1987~1789).
  • Resident, Chief Resident, Fellow, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, (1983~1992)

Education

  • Doctorate of Medical Science, Research Institute of Clinical Medicine, National Defense Medical Center, Taipei, Taiwan, 1989
  • Bachelor of Medicine, National Defense Medical Center, Taipei, Taiwan, 1983

Awards

  • The best 100 physicians of Taiwan (2008.05)
  • Teacher of the year, National Defense University, September, 2005.
  • Remarkable physician of Tri-Service General Hospital, 2001.
  • Teacher of the year, National Defense Medical Center. September, 2000.
  • Decent Man, Tri-Service General Hospital, 1998.
  • International Who's Who of Contemporary Achievement, Hall of Fame, awarded by the American Biographical Institute, July 29, 1997.
  • Men of Achievement, 17th edition, published by The International Biographical Center, Cambridge, England, July, 1996.
  • Outstanding Military Physician honored by the Ministry of Defense, Taiwan, R. O. C., 1994.
  • Scholarship of Biomedical Science for physician awarded by Academia Sinica, Taiwan, R. O. C., 1994-1995.
  • Distinguished Youth of Taipei City, 1993.
  • Remarkable physician of Tri-Service General Hospital, 1992.
  • First class Academic Medal, awarded by Ministry of Defense, R. O. C., 1989.
  • Second class Academic Medal, awarded by Ministry of Defense, R. O. C., 1983.

Research Interests

  • Dr. Chao’s current researchinterests focus on clinical trials and translational studies. The clinical trials he involves are about the development of new drugs or strategies in treating cancers and hematological disorders. In translational studies, his major effort is on the development of a novel biochemical marker, i.e. tartrate-resistant acid phosphatase 5b, in the diagnosis and monitoring of metastatic bone disease of breast cancer. He also intends to define the role and search the potential usefulness of tartrate-resistant acid phosphatase 5a in macrophage-related disorders.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 27 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Antineoplastic Combined Chemotherapy Protocols Medicine & Life Sciences
Neoplastic Stem Cells Medicine & Life Sciences
Serum Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2017

Research Output 1989 2019

  • 3961 Citations
  • 26 h-Index
  • 187 Article
  • 1 Letter
  • 1 Review article

Antrocin, a bioactive component from Antrodia cinnamomea, suppresses breast carcinogenesis and stemness via downregulation of β-catenin/Notch1/Akt signaling

Chen, J. H., T.H Wu, A., T.W Tzeng, D., Huang, C. C., Tzeng, Y. M. & Chao, T. Y., Jan 1 2019, In : Phytomedicine. 52, p. 70-78 9 p.

Research output: Contribution to journalArticle

Antrodia
Neoplastic Stem Cells
beta Catenin
Drug Resistance
Carcinogenesis
1 Citations

Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence

Wang, C. H., Chang, F. Y., Chao, T. Y., Kao, W. Y., Ho, C. L., Chen, Y. C., Dai, M. S., Chang, P. Y., Wu, Y. Y. & Lin, J. C., Feb 1 2018, In : Journal of Microbiology, Immunology and Infection. 51, 1, p. 123-131 9 p.

Research output: Contribution to journalArticle

Levofloxacin
Bacteremia
Hematopoietic Stem Cells
Bacteria
Transplants

Effect of eribulin on patients with metastatic breast cancer: multicenter retrospective observational study in Taiwan

Rau, K. M., Ou-Yang, F., Chao, T. C., Kuo, Y. L., Cheng, T. F., Chao, T. Y., Chen, D. R., Tzeng, Y. D., Wang, B. W., Liu, C. Y., Hu, M. H., Lu, Y. C., Ou, W. J., Kuo, C. H., Chuang, C. H., Kan, J. Y., Chen, F. M. & Hou, M. F., Apr 5 2018, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-9 9 p.

Research output: Contribution to journalArticle

eribulin
Taiwan
Observational Studies
Retrospective Studies
Breast Neoplasms
Myeloid Progenitor Cells
Histone Deacetylases
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Pharmaceutical Preparations
Neoplastic Stem Cells

Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit

Lin, C. S., Bamodu, O. A., Kuo, K. T., Huang, C. M., Liu, S. C., Wang, C. H., Tzeng, Y. M., Chao, T. Y. & Yeh, C. T., Jul 15 2018, In : Phytomedicine. 46, p. 93-103 11 p.

Research output: Contribution to journalArticle

Neoplastic Stem Cells
Diterpenes
Mouth Neoplasms
ovatodiolide
Heterografts

Press / Media

-ASLAN Pharmaceuticals hosts Oncology Symposium for Investors

Yi-Chen Hsieh & Tsu-Yi Chao

9/28/17

1 item of media coverage

Press/Media: Press / Media

ASLAN Hosts For Investors

Tsu-Yi Chao & Yi-Chen Hsieh

9/26/17

1 item of media coverage

Press/Media: Press / Media

ASLAN Pharmaceuticals Hosts Oncology Symposium for Investors

Tsu-Yi Chao & Yi-Chen Hsieh

9/26/17

1 item of media coverage

Press/Media: Press / Media